Daily Archive: May 20, 2020

Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials By Reuters

© Reuters.

TOKYO (Reuters) – Shares of Fujifilm Holdings Corp (T:) fell on Wednesday after Kyodo news reported that so far there has been no clear evidence of efficacy for its drug Avigan in treating the novel coronavirus in some clinical trials.

The data reported to Japan’s health ministry by hospitals treating people showing mild or no symptoms raises doubts about whether the drug can be approved by the end of this month as sought by Japan’s government, the report said, citing unidentified sources.

The government has not changed its plans to promptly seek approval for Avigan if its efficacy and safety can be confirmed, Chief Cabinet Secretary Yoshihide Suga said on Wednesday.

Fujifilm spokeswoman Kana Matsumoto said the company was not involved in the clinical research conducted mainly at Fujita Health University or other observational studies.

“Fujifilm is not aware of, nor in a position to comment on the

Read More

U.S. stocks close in the red for first time in four sessions after vaccine study questioned

U.S. stocks fell for the first time in four sessions after reports circulated that Moderna Inc.’s vaccine study, which was credited in part for Monday’s rally, didn’t produce enough critical data to assess its success. Crude oil and Treasuries gained.

The S&P 500 and Nasdaq Composite turned negative in the last hour of trading, while the Dow Jones Industrial Average extended its losses. Equities had fluctuated much of the day after optimism over the drug as a potential coronavirus vaccine sent the S&P up the most Monday in almost six weeks. Crude oil rose for a fourth day.

The Dow Jones Industrial Average fell 390.51 points, or 1.59 per cent, to 24,206.86, the S&P 500 lost 30.97 points, or 1.05 per cent, to 2,922.94 and the Nasdaq Composite dropped 49.72 points, or 0.54 per cent, to 9,185.10. The TSX rose 246 points to 14,885.

“We’re going to continue to see

Read More

If your unemployment claim was denied, here are your options

A total of 36.5 million Americans have filed for unemployment benefits since the shutdowns started in mid-March. And already the unemployment rate has soared to 14.7%—its highest since 1940.

But this flood of people seeking benefits, combined with federal changes in who is eligible, has overwhelmed states’ ability to process claims quickly. The slowness of many states to approve claims has made it difficult even for Americans who waited weeks for an answer—only to learn their claim was denied.

Having a denied claim, however, isn’t the end of the road, according to the experts Fortune spoke to. Here’s what to do next.

What to do if your unemployment claim gets denied?

Before picking a remedy for a denied jobless claim, applicants need to find out why they were denied. They should get a “notice of determination,” which spells out the specifics. An employer could have blocked it based … Read More